Patent and Publication


Patent No. (CFDA) Patent Description
ZL200410018407.3 Serum-free medium for suspension and adherent cell cultures, and the method for preparing the culture medium
ZL201110456878.2 The separation method and medium for stem cells
ZL201210195131.0 α-1,3 galactosyl-transferase fusion protein and its preparing method
ZL201210350601.6 A serum-free culture medium for cord blood stem cells
ZL201210350602.0 A serum-free culture medium for mesenchymal stem cells
201310082166.8 A xeno-free culture medium for lymphocytes
201310090742.3 A simple isolation and identification method of human placental myofibroblast cells
201310114088.5 The preparation and using method for culture medium based on stem cells factors
PCT/CN2016/081198 The method for in vitro amplification of umbilical cord blood NK cells, and kit and application

Publication:

Combination of the cytokine-induced killer and dendritic cells pulsed with antigenic α-1,3-galactosyl epitope–enhanced lymphoma cell membrane for effective B-cell lymphoma immunotherapy; DOI: 10.1016/j.jcyt.2015.09.012

Hematopoietic Stem and Progenitor Cells Can Be Enriched by Implanting Biomaterial into Spatium Intermusculare; DOI: 10.1155/2015/398642

The utility of human fallopian tube mucosa as a novel source of multipotent stem cells for the treatment of autologous reproductive tract injury DOI: 10.1186/s13287-015-0094-1